BCL2 and aneurysmal bone cyst: COO assessed by GEP, dual expression assessed by BCL2 and MYC immunohistochemistry, and CNS-IPI were evaluated using a multivariate Cox regression model, which demonstrated that high CNS-IPI and ABC/unclassified COO were associated with a higher CNS relapse risk [28].